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In this issue of the Journal, Mahmarian et al. (1) report the
results of their studies of smoking, exercise and nicotine
replacement in patients with myocardial ischemia. Briefly, in
36 patients with a reversible perfusion defect while smoking,
substitution of smoking with at least a 14-mg nicotine patch
was associated with a reduction in the size of the reversible
perfusion defect and an increase in exercise duration. Despite
higher serum nicotine levels with the patch (and some subjects
continued to smoke), exercise duration increased by about
10% and time to significant ST segment depression increased
by nearly 20%. The average peak rate–pressure product did
not change, but the size of the ischemic perfusion defect
declined by one-third. These data indicate that inhaled carbon
monoxide is the agent in cigarette smoke that causes acute
ischemia. Because ischemic burden predicts outcome in pa-
tients with coronary heart disease (2), we would have to
conclude that even for patients with heart disease, receiving
nicotine from patches is safer than receiving nicotine from
cigarettes.
This is important news not only for our patients but also for
us as cardiologists. Fifty percent of smokers die of smoking-
related causes (3), and there is hardly a cardiologist among us
who does not have the clinical impression that smoking is a
profound hazard for our patients. This impression is borne out
by data. Salonen (4), Mulcahy (5) and Wilhelmsson et al. (6)
have all documented that continuing to smoke doubles the risk
of death for patients with heart disease. Calculations from
these data indicate that continued smoking after a myocardial
infarction halves subsequent life expectancy. This makes smok-
ing cessation among the most efficacious actions that can be
taken by an individual with coronary heart disease.
Last year, the Agency for Health Care Policy and Research
(AHCPR) released its guideline for smoking cessation inter-
ventions in clinical practice (7). The expert panel reviewed
.3,000 articles and concluded that smoking cessation inter-
ventions are effective. The three attributes associated with
efficacy are (1) skills building, (2) social support for quitting,
and (3) nicotine replacement. There is randomized trial evi-
dence that an intervention as simple as making smoking a vital
sign increases the probability that a patient will quit (8), and in
a very recent report, Houston Miller et al. (9) describe an
efficacious intervention that is feasible for cardiologists.
Skills building interventions teach the patient how to resist
cues to smoke. The teachable skills that benefit the patient the
most are the ability to recognize situations that have triggered
the urge to smoke in the past and the ability to plan—either to
avoid the setting altogether or substitute a behavior for
smoking. In particular, planning to avoid alcohol in the first
few weeks of a smoking cessation attempt is critical. Making
the home, car and office smoke free is also an effective and
legitimate action to take to avoid both cues to smoke and the
hazards of environmental tobacco smoke.
Social support for quitting is the positive support that the
smoker gets from family, friends, co-workers and health care
professionals for taking action toward smoking cessation and
for abstaining from tobacco. The smoker may have trouble
asking his or her family and friends but should be able to rely
on health care professionals for the support that helps them
get through the first few months of the quit attempt and
reinforces their desire to remain a nonsmoker throughout their
lifetime. Even simple and brief words, “I want you to quit, will
you let me arrange an appointment with a smoking cessation
counselor?” or “I’m glad that you’ve quit smoking, my therapy
is more effective when you don’t smoke,” are effective (7).
Make the message positive. Reinforcing actions to quit is far
more effective than threatening the bad outcomes associated
with smoking.
Nicotine replacement doubles the probability of a successful
quit attempt in most trials. Nicotine replacement can now be
obtained through gum, patches or nasal spray. Let the patient
define the delivery system of choice. Karl Olaf Fagerstrom, the
pioneering nicotine-dependence researcher, told me last fall
that he gives his patients a sample “kit” of gum, patches and
spray to take home with them. The patients experiment with
the three delivery systems and choose the one that they find
most pleasing. Because no delivery system is clearly more
effective than the others, this seems to be an effective strategy
for matching the delivery system to the patient. The report by
Mahmarian et al. (1) in this issue of the Journal ought to give
cardiologists the confidence to prescribe nicotine replacement
therapy.
Acknowledging the impact of the organizational environ-
ment on professional behavior, the AHCPR expert panel
recommended that health care systems make institutional
changes to support the systematic identification of, and inter-
vention with all tobacco users (7). They also recommend that
clinicians be reimbursed for providing effective treatments.
When I chaired the American College of Cardiology’s
Subcommittee on the Implementation of Preventive Cardiol-
ogy from 1989 to 1993, we interviewed a randomly generated
sample of cardiologists and primary care physicians about why
they did not provide preventive cardiology services to their
patients. The cardiologists responded, “When I’m asked to
treat the patient, it’s for the acute event. I don’t want to
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interfere with the primary care physician’s relationship with
the patient.” Nearly every primary care physician said, “When
the cardiologist writes a letter that describes the left ventricular
function and coronary artery anatomy in detail but doesn’t
mention smoking, I’m led to believe that it isn’t important.”
This confusion should not and need not happen and should not
be an excuse for our inaction.
We recently surveyed ;6,000 patients who had been seen
by primary care physicians (10). Fewer than 50% of the
smokers said that they had been advised to quit when they
visited their doctor. This shows no improvement from 1987
(11) or 1991 (12) and is not a result of patients forgetting that
their doctor talked to them about smoking. A recent report
clearly documents that patients overreport the rates at which
their physicians advise them to quit smoking (13).
We cardiologists cannot put all of medicine’s house in
order, but we can put ours in order. Most of us in cardiology
approach our patients systematically in key situations; we use
nurses to systematically prepare the patient for the catheter-
ization laboratory and manage our cardiac rehabilitation pro-
grams. We also have systems to communicate with the physi-
cians who refer their patients to us. With clear instruction, the
catheterization laboratory and cardiac rehabilitation nurses
can use their skills to address the smoking habits of our
patients and advise nicotine replacement when indicated. For
a patient who has recently used tobacco, it is easy to ensure
that no letter goes out to a primary care physician without the
words
I have advised the patient that abstinence from tobacco is the
most important step that an individual can take to optimize
their health. My team has given the patient advice about how to
become and remain a nonsmoker. I would appreciate it if you
would take the opportunity at each visit to reinforce any efforts
that the patient makes to become and remain an ex-smoker.
Just as these words reside in my referring physicians letter
template, they or similar words should reside in yours.
At the bottom line, the message is, “Don’t intellectualize
why you don’t give smoking cessation advice and assistance.
Just do it.” Then, at the end of the day, know that if every
cardiologist has done what you have done, cardiology has
become part of the solution and is no longer part of the
problem.
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